Thirdly, TAMs inhibit the recruitment of T cells to tumor sites by producing peroxynitrites and nitrifying CCL2 and CCL5, thereby preventing chemotaxis of CAR-T and other T cells to the tumor, reducing their effectiveness (134). The gene discussed is CCL5; the disease is neoplasm.